| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.0M | +44.7% |
| Cost of Revenue | $6.3M | +54.2% |
| Gross Profit | $1.7M | +17.1% |
| R&D Expense | $585K | +143.8% |
| SG&A Expense | $1.4M | +27.7% |
| Operating Income | -$3.8M | -30.4% |
| Interest Expense | $16K | -70.9% |
| Income Tax | $0 | — |
| Net Income | -$3.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -27.0% |
| Current Assets | $3.4M | -29.9% |
| Total Assets | $3.7M | -25.3% |
| Current Liabilities | $614K | -32.6% |
| Total Liabilities | $801K | -12.0% |
| Stockholders' Equity | $2.9M | -28.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | -6.3% |
| Capital Expenditures | $11K | -27.1% |
| Investing Cash Flow | -$11K | +27.1% |
| Financing Cash Flow | $2.1M | -66.0% |
| Free Cash Flow | -$2.9M | -6.1% |
| -27.9% |
| EPS (Basic) | -$0.50 | +16.7% |
| EPS (Diluted) | -$0.50 | +16.7% |